Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantile Health
New York, NY, USA
- Ownership
- Private
- Development stage
- Other
01
Overview
Quantile Health has developed a unique risk transfer platform enabling U.S. payers and gene therapy manufacturers to improve access to high-cost, life-saving therapies for rare diseases, with payer subscription models that remove catastrophic tail risk. The company has raised seed/early venture funding and has begun commercial partnerships with both payers and manufacturers.[3]
- Therapeutic areas
- Rare Diseases
- Modalities
- Gene therapyCell therapyAntisense oligonucleotide therapy
- Industry
- Biomedical IT and Biomedical Data Platforms
02
Partnerships
Munich Re Ventures (investor, potential strategic insurance/finance partner)First Round Capital (investor)Correlation Ventures (investor)
Beyond the preview
Go deeper on Quantile Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Quantile Health.